Sunovion Pharmaceuticals’ apomorphine sublingual under-the-tongue film (APL-130277) — now under review for approval — significantly improved motor fluctuations, or…
Articles by José Lopes, PhD
The U.S. Food and Drug Administration granted Voyager Therapeutics’ gene therapy candidate VY-AADC regenerative medicine advanced therapy (RMAT)…
Accumulation of alpha-synuclein protein in the retina could be a biomarker of Parkinson’s disease severity, a new study suggests. The…
Mutations in two specific genes affect how nerve cells work in the brain, disrupting sleep patterns in Parkinson’s patients, a…
Axovant Sciences licensed the exclusive worldwide rights from Oxford BioMedica to develop and market AXO-Lenti-PD, a gene therapy…
Antiparkinsonian medications may cause premature ejaculation in men with Parkinson’s, according to a case series that followed eight patients. The…
Understanding how two proteins, both enzymes, work to disassemble “stress granules” — clumps of molecules that form when cells are…
A new and experimental deep brain stimulation (DBS) system uses feedback from the brain to fine-tune its signaling in response to signs…
Impaired intake of neurotransmitters leads to accumulation of toxic dopamine and neurodegeneration in patients with Parkinson’s disease, according to…
Even low-level exposure to certain pesticides disrupts cells in a way that mimics the effects of mutations linked Parkinson’s disease —…